Holen Sie sich die Stockscreener-App
8.37
0.48%
0.04
Handel nachbörslich:
8.37
Schlusskurs vom Vortag:
$8.33
Offen:
$8.3
24-Stunden-Volumen:
870.09K
Relative Volume:
1.21
Marktkapitalisierung:
$596.97M
Einnahmen:
$133.62M
Nettoeinkommen (Verlust:
$-177.37M
KGV:
-2.8962
EPS:
-2.89
Netto-Cashflow:
$23.50M
1W Leistung:
+3.98%
1M Leistung:
+5.28%
6M Leistung:
-40.85%
1J Leistung:
-49.67%
1-Tages-Spanne:
$8.0538
$8.54
1-Wochen-Bereich:
$7.8301
$8.69
52-Wochen-Spanne:
$6.92
$27.24
Xencor Inc Stock (XNCR) Company Profile
Firmenname
Xencor Inc
Sektor
Branche
Telefon
626-305-5900
Adresse
465 N. HALSTEAD ST., PASADENA, CA
Vergleichen Sie XNCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
8.37 | 609.81M | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Eingeleitet | William Blair | Outperform |
| 2024-12-12 | Eingeleitet | Wells Fargo | Overweight |
| 2024-12-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | Bestätigt | BTIG Research | Buy |
| 2024-02-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | Eingeleitet | BofA Securities | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-10-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | Eingeleitet | JP Morgan | Overweight |
| 2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-02-11 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-01-21 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-02-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | Eingeleitet | Barclays | Underweight |
| 2020-02-25 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-01-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-11-20 | Fortgesetzt | Guggenheim | Neutral |
| 2019-08-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-08-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | Eingeleitet | Mizuho | Buy |
| 2019-04-12 | Eingeleitet | Guggenheim | Buy |
| 2019-03-27 | Eingeleitet | Berenberg | Buy |
| 2019-03-15 | Eingeleitet | Raymond James | Outperform |
| 2018-09-10 | Fortgesetzt | BTIG Research | Buy |
| 2018-03-28 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-03-02 | Eingeleitet | Instinet | Neutral |
| 2017-03-02 | Bestätigt | Wedbush | Outperform |
| 2016-10-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-12-22 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-08-05 | Bestätigt | MLV & Co | Buy |
| 2015-02-12 | Bestätigt | Oppenheimer | Outperform |
| 2015-01-28 | Bestätigt | MLV & Co | Buy |
| 2014-07-11 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Xencor Inc Aktie (XNCR) Neueste Nachrichten
Does Xencor Inc. have declining or rising EPSJuly 2025 Sentiment & Safe Entry Trade Signal Reports - khodrobank.com
Xencor at Cantor Conference: Strategic Advances in Immunology - Investing.com
Will Xencor Inc. announce a stock splitQuarterly Trade Report & Consistent Profit Trading Strategies - khodrobank.com
Is Xencor Inc. a candidate for recovery playWeekly Stock Recap & High Return Stock Watch Alerts - Newser
Real time scanner hits for Xencor Inc. explainedMarket Performance Report & Technical Pattern Recognition Alerts - Newser
Xencor Inc. stock trend outlook and recovery pathJuly 2025 Summary & Free Technical Confirmation Trade Alerts - Newser
Evaluating Xencor Inc. with trendline analysisQuarterly Earnings Summary & Fast Gain Stock Trading Tips - Newser
Earnings visualization tools for Xencor Inc.Quarterly Market Review & Smart Allocation Stock Tips - Newser
Xencor at Wells Fargo Conference: Strategic Advances in Biotech - Investing.com
What earnings revisions data tells us about Xencor Inc.2025 Trade Ideas & Accurate Buy Signal Notifications - Newser
Xencor Shares Fall After BofA Securities Downgrade - MarketScreener
Erasca, Candle, Xencor drop as BofA downgrades on lack of near-term catalysts - Seeking Alpha
Sector Update: Health Care - MarketScreener
B of A Securities Downgrades Xencor to Neutral with $12 PT. - AInvest
Intraday pattern recognizer results for Xencor Inc.Portfolio Update Summary & Risk Managed Trade Strategies - Newser
BofA Securities Downgrades Xencor to Neutral From Buy - MarketScreener
Xencor Inc. stock outlook for YEARInsider Buying & Verified Entry Point Detection - Newser
Xencor Inc. stock trendline breakdownEarnings Growth Report & Stepwise Swing Trade Plans - Newser
News impact scoring models applied to Xencor Inc.July 2025 Retail & Technical Pattern Alert System - Newser
How to build a custom watchlist for Xencor Inc.Inflation Watch & Expert Approved Trade Ideas - Newser
Is Xencor Inc. reversing from oversold territoryGap Down & Weekly Setup with High ROI Potential - Newser
Published on: 2025-09-03 03:15:31 - Newser
Is it time to cut losses on Xencor Inc.Portfolio Update Report & Verified Chart Pattern Signals - Newser
Automated trading signals detected on Xencor Inc.Market Performance Summary & Low Drawdown Trading Techniques - Newser
Will earnings trigger a reversal in Xencor Inc.Weekly Risk Summary & Reliable Intraday Trade Alerts - Newser
Is Xencor Inc. stock ready for a breakoutMarket Movers & Safe Entry Trade Reports - Newser
Advanced analytics toolkit walkthrough for Xencor Inc.Weekly Gains Report & Verified Swing Trading Watchlist - Newser
Real time social sentiment graph for Xencor Inc.Weekly Trade Report & Weekly High Potential Stock Alerts - Newser
Using Ichimoku Cloud for Xencor Inc. technicals2025 Market Trends & Long Hold Capital Preservation Plans - Newser
Full technical analysis of Xencor Inc. stockWeekly Loss Report & Free Growth Oriented Trading Recommendations - Newser
Is Xencor Inc. forming a bottoming baseJuly 2025 EndofMonth & Trade Opportunity Analysis Reports - Newser
Will Xencor Inc. stock recover after earnings2025 Winners & Losers & Safe Capital Growth Tips - khodrobank.com
Can Xencor Inc. benefit from deglobalizationProduct Launch & Technical Pattern Alert System - khodrobank.com
Key resistance and support levels for Xencor Inc.Portfolio Value Report & Free Safe Entry Trade Signal Reports - Newser
Reversal Traders Monitor Xencor Inc. for Entry2025 Top Gainers & Growth Focused Investment Plans - beatles.ru
Trend analysis for Xencor Inc. this weekWeekly Profit Summary & Community Verified Watchlist Alerts - Newser
Multi asset correlation models including Xencor Inc.Earnings Growth Summary & Growth-Oriented Investment Plans - Newser
Will Xencor Inc. stock recover after recent dropJuly 2025 Earnings & Risk Adjusted Buy and Sell Alerts - Newser
Finanzdaten der Xencor Inc-Aktie (XNCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Xencor Inc-Aktie (XNCR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| GUSTAFSON KURT A | Director |
Jun 16 '25 |
Sale |
9.22 |
2,993 |
27,595 |
20,183 |
| GORMAN KEVIN CHARLES | Director |
Jun 16 '25 |
Sale |
9.22 |
3,173 |
29,255 |
18,905 |
| Feigal Ellen | Director |
Jun 16 '25 |
Sale |
9.22 |
2,993 |
27,595 |
19,183 |
| RANIERI RICHARD J | Director |
Jun 16 '25 |
Sale |
9.22 |
2,993 |
27,595 |
19,183 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):